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Effects over Time of Feeding a 8-Adrenergic Agonist to Wether
Lambs on Animal Performance, Muscle Growth, Endogenous
Muscle Proteinase Activities, and Meat ~ e n d e r n e s s ' ~ ~
T. D. Pringle*, C. R. Calkins*, M. Koohmaraiet, and S. J. Jones*
"Department of Animal Science, University of Nebraska-Lincoln, Lincoln 68583-0908 and
+Roman L . Hruska U.S. Meat Animal Research Center, ARS, USDA, Clay Center, NE 68933

ABSTRACT: Forty wether lambs were used in a 2
x 4 factorial arrangement to determine the response of
animal performance, muscle growth, proteinase activity, and meat tenderness to 0-adrenergic agonist
(BAA) supplementation. Lambs were fed a finishing
diet with or without 4 ppm of L644,969and slaughtered
after 0, 2, 4, and 6 wk of treatment. The ADG was
higher ( P < .05) in the treated than in the control
lambs after 2 wk and returned to control levels
thereafter. Semitendinosus weight and calpastatin
activity were higher and p-calpain activity was lower
in the treated than in the control lambs after 2, 4, and
6 wk. Cathepsin B activity was higher ( P < .0 1) and
cystatin-like activity was lower ( P c .05) after 2 wk in
treated than in control lambs but returned to control
levels thereafter. Longissimus protein:DNA was
higher after 4 ( P < .05) and 6 ( P < .01) wk in the

treated lambs than in the controls. The concentration
of RNA and RNA:DNA ratio were higher ( P < .0 1) in
the longissimus and semitendinosus muscles in the
treated lambs after 2 wk and remained higher
throughout the study. Semitendinosus protein and
RNA content were higher after 2, 4, and 6 wk and
DNA content was higher after 2 and 6 wk in the
treated than in the control lambs. Longissimus shearforce values were higher ( P < .001) in the treated
than in the control lambs at all slaughter end points.
These data indicate a rapid alteration of muscle
growth, activity of the calpain-calpastatin system, and
meat tenderness during BAA treatment. It also seems
that the BAA-stimulated muscle growth is closely
related to the activity of the calpain-calpastatin
system.
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Introduction
Protein turnover involves two cellular processes,
protein synthesis and degradation. Protein turnover
decreases an animal's growth efficiency, because of
energy lost during the breakdown and resynthesis of
proteins. These processes are inefficient but necessary
for maintaining available pools of amino acids, repairing erroneous proteins, and removing proteins not
properly incorporated into their subcellular locations
(Reeds, 1989). Young et al. (1975) suggested that 15
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to 25% of the energy consumption of growing animals
was used for protein turnover. Thus, a better understanding of the regulation of in vivo protein degradation could allow large alteration of animal growth
efficiency and consequently reduce the cost of production.
The 6-adrenergic agonists have been shown to
increase muscle accretion and decrease fat accretion
(Yang and McElligott, 1989). These compounds have
been reported to regulate both protein synthesis
(Maltin et al., 1987; Helferich et al., 1990) and
protein degradation (Reeds et al., 1986; Bohorov et
al., 1987). In most cases, the greatest effect is on
protein degradation. Recently, the endogenous proteinases ( t h e calpain system and the cathepsins) have
been studied during P-adrenergic-agonist supplementation (Forsberg et al., 1989; Kretchmar et al., 1990;
Koohmaraie et al., 1991). Most of the data indicate
that activity of calpastatin, the endogenous inhibitor
of p- and m-calpain, increases substantially during the
treatment period. Although data from laboratory
animals have shown short-term responses to
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Table 1. Dry matter composition of the diet
Ingredient

% DM

64.83
20.00

Corn
Alfalfa hay
Molasses
Soybean meal (60% C P )
Limestone
Dicalcium phosphate
Salt
Vitamin premixa
S h e e ~trace mineral memixb

6.00
7.94

.82
.06
.30
.02
.03

'Vitamin A, 15,000 IUig, vitamin D, 3,000 IUig; vitamin E, 3.75
IU/
f77.7% soyhulls; 12.3% MnS04; 7.0% ZnC03; 3.0% oil or fat.

P-adrenergic agonists (Reeds et al., 1986; Maltin et
al., 1987), most of the data collected in livestock have
been over long time periods. Therefore, this study was
designed to investigate the response time of muscle
growth, endogenous proteinase activity, and meat
tenderness to P-adrenergic-agonist treatment in
wether lambs.
Experimental Procedures

Experimental Design. Forty wether lambs (112
Finnsheep, 114 Dorset, 114 Ramboillet) with an
average weight of 35.2
.6 kg were assigned to a
factorial arrangement with two dietary treatments
(control and treated) and four treatment periods (0,
2, 4, and 6 wk). The lambs were ranked by weight,
divided into five groups of eight, and randomly
assigned to the eight treatments. The control diet was
a corn, alfalfa hay diet containing 14% CP (Table 1).
The treated diet consisted of 4 ppm of the 6-adrenergic
agonist L644,969(Merck, Sharp and Dohme Research
Laboratories, Rahway, N J ) added to the control diet.
Daily feed consumption and biweekly live weights
were recorded. The lambs were weighed on three
consecutive days to start the test. After the assigned
treatment period, the lambs were weighed, transported to the University of Nebraska Meat Laboratory, and slaughtered. Within 45 min postmortem, the
longissimus muscle was removed from one randomly
chosen side and sampled for determination of activity
of the calpain system and cathepsins B and L as well
as concentrations of DNA, RNA, and protein. Within 1
to 2 h postmortem, the semitendinosus muscle from
the same side was removed intact, weighed, and
sampled for determination of DNA, RNA, and protein
concentration.
The longissimus muscle from the other side of the
carcass was removed after it had been stored for 48 h
at 4°C and divided in half, and the halves were
randomly assigned to either 2 or 7 d of aging. A
5-g slice of the loin was removed for sarcomere length
determination and stored at -20°C. The loin halves
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were vacuum-packaged and stored at 4°C until
completion of the assigned aging time. The loin halves
were then frozen at -35°C and stored at -20°C until
shear force was measured.
Determination o f Calpain Activity. Activity of pcalpain, m-calpain, and calpastatin were determined
on unfrozen, prerigor muscle according to the procedures of Koohmaraie ( 1990), with some slight modifications. Longissimus muscle samples (50 g ) were
homogenized in 2.5 volumes of extraction buffer (100
mM Tris, 5 mM EDTA, and 10 mM 0-mercaptoethanol
[MCEI, pH 8.3). The samples were then centrifuged,
filtered, and dialyzed overnight in dialysis buffer (20
mM Tris, 5 rnM EDTA, 10 mM P-MCE, pH 7.5). After
dialysis, the samples were loaded onto anion exchange
(2-[diethylamino] ethyl ether [DEAEI-Sephacel;
Sigma Chemical, St. Louis, MO) columns and washed
with three volumes of elution buffer (20 mM Tris, . l
mM EDTA, and 10 mM P-MCE, pH 7.35). The
samples were then eluted using a linear NaCl
gradient (0 to 400 mM), and 130 fractions ( 6 mL)
were collected. Activity of the proteinases and the
inhibitor were determined using a casein solution
(100 mM Tris, 1 mM NaN3, 5 mM CaC12, 1 pLlmL of
0-MCE, and 5 mg1mL of casein, pH 7.5). One unit of
proteinase activity was defined as the amount of
enzyme necessary to cause an increase of 1.0 optical
density unit at 278 nm. One unit of inhibitor activity
was defined as the amount of calpastatin necessary to
inhibit one unit of DEAE-purified m-calpain activity.

Cathepsin B and L and Cystatin-like Activity.
Activity of the cathepsins and their inhibitor were
determined on frozen muscle samples according to
method D of Koohmaraie and Kretchmar (1990).
Longissimus samples ( 5 g ) were homogenized in
seven volumes of extraction buffer (50 mM sodium
acetate, 1 mM EDTA, 100 mM NaC1, and .2% Triton
X-100, pH 5.0). After homogenization, the samples
were centrifuged and filtered and 2 mL of the extracts
was passed through a papain-Sepharose affinity
column to remove the cystatins, endogenous inhibitors
of the cathepsins. The samples, pre- and postcolumn,
were assayed using synthetic substrates (cathepsin B,
Z-Arg-Arg-NMec; cathepsin B + L, Z-Phe-Arg-NMec;
Bachem Fine Chemicals, Torrence, CA). The substrate used for cathepsin L is also a substrate for
cathepsin B; therefore, the specific activity is reported
as B + L. Specific activity of the cathepsins was
reported
as
the
nanomoles
of
NMec
released.minute-l.gram of tissue. Cystatin-like activity was reported as the ratio of post-:precolumn
cathepsin B + L activity.
Nucleic Acid and Protein Concentrations. Concentrations of DNA were determined fluorometrically
using Hoechst 33258 (Sigma Chemical; Labarca and
Paigen, 1980). Concentrations of RNA were measured
spectrophotometrically using the procedures of Munro
and Fleck ( 19691, and protein concentrations were
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Table 2. Changes in average daily gain, hot carcass weight, dressing percentage,
and longissimus cathepsin B, B + L, and cystatin-like activity of lambs
after P-adrenergic agonist (BAA) treatment
Time on feed, wk
Trait

0

2

6

4

Average daily gain, kg
Control
BAAa
Hot carcass wt, kg
Controla
BAAa
Dressing percentage, %
Control
BAAa
Cathepsin B, nmol ~ ~ e c . r n i n - l . ~ - '
Control
sAAb
Cathepsin B + L,
nmol ~ ~ e c . m i n - l , ~ - l
Control
BAA
Cystatin-like activityC
Control
BAA
aLinear effect, P < .01.
b ~ u a d r a t i ceffect, P < .05.
'See text for description.
*, **Means within a trait, a t a specific time on feed, differ, P < .05 and .01, respectively.

determined using the biuret procedure of Gornall et al.
(1949).
Determination o f Sarcomere Length. Sarcomere
lengths were measured according to the procedure of
Cross et al. (1981), modified for use with a Zeiss
microscope (LEP, Scarsdale, NY) attached to a
BioQuant System VI digitizer (Houston Instrument,
Austin, TX). Longissimus samples ( 5 g ) were
homogenized in eight volumes of 250 mM sucrose and
measurements recorded for 10 adjacent sarcomeres on
each of 10 different myofibrils.

Determination o f Warner-Bratzler Shear Force.
Loin roasts used for Warner-Bratzler shear (WBS)
force determination were thawed at 4°C for 24 h and
oven-roasted to an internal temperature of 70°C.
Internal temperatures were monitored using copperconstantan thermocouples. Six to eight cores (1.3 cm)
were removed randomly from each sample, parallel to
the longitudinal orientation of the fiber. Cores were
sheared once using the WBS blade attached to an
Instron Universal Testing Machine (Model 1123,
Instron, Canton, MA).
Statistical Analyses. The data were analyzed using
ANOVA for a completely randomized design (Steel
and Torrie, 1980). The treatment means for animal
performance, muscle weight, proteinase activity, nucleic acid and protein concentration, and sarcomere
length of treated and control lambs at specific
slaughter end points were separated using single df

contrasts. The WBS means for treated and control loin
portions at specific slaughter end points and at specific
aging times were separated using single df contrasts.
The means for 2 and 7 d of aging at specific slaughter
end points in treated and control loin portions were
also separated using single df contrasts. The data are
presented as means SEM. Different values for SE
within a trait are due to differences in the number of
observations for means.

+

Results

Animal Performance and Muscle Growth. Average
daily gain was higher ( P < .05) after 2 wk of
treatment and returned to control levels thereafter
(Table 2). Daily feed intake and feed efficiency were
not affected ( P > .30 and > .45, respectively) by BAA
treatment (data not shown). Hot carcass weight was
numerically higher ( P > .lo; Table 2 ) and backfat was
numerically lower ( P > .lo; data not shown) in the
BAA lambs than in control lambs. In accordance with
most BAA studies, dressing percentage was increased
by 6% after 2 wk ( P < .05) and by 8% after 4 and 6 wk
( P c .05) of BAA treatment. Muscle accretion,
indicated by semitendinosus weight (Figure I ) , was
higher in BAA-treated lambs than in control lambs
after 2 wk ( P < .05) and remained higher after 4 and
6 wk ( P c .01) of BAA supplementation. This
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returned to control levels after 4 wk (Table 2).
Cathepsin B + L activities did not differ ( P > .25)
between treated and control lambs (Table 2 j. Thus, it
seems unlikely that the increased muscle accretion
(Figure 1) of the treated lambs was due to altered
activity of lysosomal proteinases.

Time on feed (wk)

Figure 1. The response of semitendinosus weight to
0-adrenergic agonist feeding in lambs.

indicates that the increased growth rate of the BAAtreated lambs is primarily due to increased muscling.
Calpains and Calpastatin Activities. Activity of mcalpain was not significantly affected ( P > .60) by
BAA treatment (data not shown). Activity of pcalpain was significantly lower after 2 and 6 wk of
BAA treatment and tended to be lower ( P < .20) after
4 wk of treatment (Figure 2). Conversely, calpastatin
activity was 73% higher in BAA-treated lambs than in
control lambs after 2 wk ( P < .0 1) and remained
significantly higher throughout the study (Figure 3).
Collectively, these data indicate a decrease in the
proteolytic capacity of BAA-treated muscle; the
greatest response occurred within 2 wk.

of cell mass or size, was greater in the BAA-treated
than in the control lambs after 2, 4 ( P < .05), and 6
wk ( P < .01). Longissimus protein concentration
increased linearly in both the treated ( P < .05) and
control ( P < . l o ) lambs but did not differ significantly
at any slaughter end point. The increased protein:
DNA ratio in the treated lambs is consistent with
previous data on BAA treatment (Kim et al., 1987;
Koohmaraie et al., 1991) and agrees with the theory
that BAA-stimulated muscle growth is hypertrophic.
Longissimus RNA concentrations in the control
lambs decreased progressively during the 6-wk feeding
trial (Table 3 ) . The RNA concentrations in the BAAtreated lambs were 21% higher than in the control
lambs after 2 wk ( P < .0 1) and remained higher
throughout the study. Longissimus RNA:DNA ratio,
an indicator of transcriptional activity, exhibited the
same pattern of changes as RNA concentration during
the study. Conversely, the protein:RNA ratio, an
indicator of translational activity, decreased to a value
less than that in control lambs after 2 wk ( P < .05j of
BAA treatment and remained lower through 4 and 6
wk (Table 3 ) .

Sernitendinosus Nucleic Acid and Protein Concentrations and Contents. Unlike the longissimus muscle,

treated lambs than in control lambs after 2 wk and

the semitendinosus protein:DNA ratio was not significantly affected ( P > .5) by BAA treatment (Table 4).
Likewise, BAA treatment did not affect ( P > .5) the
protein concentration (Table 4). Changes in the RNA
concentration of the semitendinosus muscle were
similar to those in the longissimus (Table 4 ) ; RNA

p-CALPAIN ACTIVITY

CALPASTATINACTIVITY

Cathepsins B and B + L and Cystatin-like Activities. Cathepsin B activity was higher ( P < .0 1) and
cystatin-like activity was lower ( P < .05) in BAA-

I

**

(Treatment meana differ, P < .05)

II

I

I

I

0

2

4

6

Time on feed (wk)

Figure 2. The response of longissimus muscle p calpain activity to P-adrenergic agonist feeding in
lambs.

2

4

Time on feed (wk)

Figure 3. The response of longissimus muscle
calpastatin activity to P-adrenergic agonist feeding in
lambs.
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Table 3. Changes in longissimus protein:DNA ratio, protein and RNA
concentration, and RNA:DNA and protein:RNA ratios of lambs
after P-adrenergic agonist [BAA) treatment
Time on feed, wk
Trait
Protein:DNA, mg/mg
Control
BAAa
Protein, mglg of tissue
Control

BAA^

RNA, mgig of tissue
Controla
BAAC
RNA:DNA, mgimg
Controla

BAA^

Protein:RNA, mgimg
Controla

BAA^

aLinear effect, P i .01.
b ~ i n e a reffect, P i .05.
cQuadratic effect, P < . l o .
d ~ u a d r a t i ceffect, P < .05.
*, **Means within a trait, a t a specific time on feed, differ a t P < .05 and .01, respectively.

< .05) and 4 ( P < .01) wk. However, in contrast to the
longissimus data, semitendinosus RNA:DNA ratio in
BAA-fed lambs was similar to controls after 6 wk of
treatment (Table 3 and 4 ) . Although lower a t all end
points, the protein:RNA ratio of the semitendinosus
muscle was only significantly lower ( P < . l o ) after 4
wk of BAA treatment (Table 4).

concentration in the control lambs decreased progressively during the feeding period, whereas RNA concentration in the BAA-fed lambs increased after 2 wk and
then decreased to levels found in the 0-wk treated
lambs. As previously noted in the longissimus muscle,
the semitendinosus RNA:DNA ratio was higher in the
treated animals than in the control animals after 2 ( P

Table 4. Changes in semitendinosus protein:DNA ratio, protein and RNA
concentration, and RNA:DNA and protein:RNA ratios of lambs
after /3-adrenergic agonist (BAA) treatment
Time on feed, wk
Trait

0

Protein:DNA, mgimg
Control
BAA
Protein, mg/g of tissue
Control
BAAa
RNA, m g of tissue
Control
BAAC
RNA:DNA, m d m g
Control

%'

BAA^

Protein:RNA, mg/mg
controlb
BAAa

290.2
279.8

2

+
+

4

6

15.6
15.6

+

251.2
8.4
246.3 f 8.4
563.9 f 20.0
537.5 f 17.9
.66 f
.61 -f-

.04
.03

445.7 f 21.9
459.1 f 19.6

aLinear effect, P c .05.
b ~ i n e a reffect, P < .01.
CQuadratic effect, P < .lo.
d ~ u a d r a t i ceffect, P c .01.
+, *, **Means within a trait, a t a specific time on feed, differ a t P <

.lo, .05, and

.01, respectively.
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WARNER-BRATZLER SHEAR FORCE

**

0

1 1

I

I

I

0

2

4

6

Time on feed (wk)

Figure 4. The response of Warner-Bratzler shear
force to 0-adrenergic agonist feeding and subsequent
aging in lamb longissimus muscle. Within a time
period, L644,969 means were higher (P < .001) than
controls.

Nucleic acid and protein contents were calculated
by multiplying the concentrations of each by the
weight of the semitendinosus muscle. Although the
concentrations of DNA were lower in the BAA-treated
animals than in the controls (data not shown), the
total amount of DNA (Table 5 ) was higher in the
treated lambs after 2 wk ( P < . l o ) and 6 wk ( P < .01).
Similar data have been reported in lambs (Beermann
et al., 1987) and rabbits (Forsberg et al., 1989);
however, Koohmaraie et al. (1991) and Kim et al.
(1987) reported a decrease in the concentrations of
DNA in treated animals without a change in the total
amount of DNA. Because of the combined responses in
muscle weight and RNA and protein concentrations,
the RNA and protein content of the semitendinosus
muscle in BAA-treated lambs was higher ( P < .05)
than in control lambs at all end points.

Longissirnus Tenderness and Aging. The WarnerBratzler shear force values for longissimus muscle
aged 2 d (WBS2) and 7 d (WBS7) are presented in
Figure 4. Both the WBS2 and WBS7 values were
higher ( P < .001) in the treated lambs than in the
control lambs after 2, 4, and 6 wk. Sarcomere length
was not affected ( P > .25) by BAA treatment (data
not shown). The tenderness data agree with the
findings of Hamby et al. (1986), Miller et al. (1988),
Morgan et al. (1989), and Koohmaraie and Shackelford (1991), who also found that BAA treatment
decreased muscle tenderness. Our data also concur
with the observation of Merkel (1988) that the
decreased tenderness in BAA-treated animals could
not be explained by muscle shortening.
The response to aging, indicated by the difference
between WBS2 and WBS7, varied with treatment
(Figure 4). There were no significant differences
between WBS2 and WBS7 in the BAA-treated lambs
after 2 and 6 wk of treatment; however, after 4 wk of
BAA treatment WBS7 was 21% lower ( P < .05) than
WBS2. This was due mainly to an increase in the
WBS2 value at that end point and not to a reduction
in WBS7. In the control lambs, WBS7 was 35 and 32%
l o w e r t h a n W B S 2 a f t e r 4 ( P < . 0 5 ) a n d 6 ( P < . l 0 ) wk
of the study, respectively. The decreased response to
aging in BAA-treated lambs has also been reported by
Kretchmar et al. (1990), Koohmaraie and Shackelford
(1991), and Koohmaraie et al. (1991).
Discussion
The effects of BAA on animal performance vary. In
our study, L644,969
supplementation increased ADG
during the first 2 wk of treatment and had no effect
thereafter. Other studies have shown early increases
in ADG (Beermann et al., 1986; Moloney et al., 1990),
longer-term effects on ADG (Kim et al., 1987;

Table 5. Changes in DNA, RNA, and protein content of lamb
semitendinosus muscle after 0-adrenergic agonist (BAA] treatment
Time on feed, wk
Trait

0

2

4

6

DNA, mg
Control
BAAa
RNA, mg
Control

78.3 f 6.1
78.9 k 6.1

82.7 f 6.1t
98.5 f 6.1

89.3 i 6.1
98.6 k 6.1

BAA^^

50.7 k 4.2
48.7 i 3.7

49.7 f 3.7**
68.3 f 3.7

50.2 i 3.7**
68.3 i 3.7

48.9 3.7**
70.3 f 3.7

Protein, g
Control
BAAa

22.9 i 1.8
22.0 i 1.8

24.8 f 1.8*
31.0 f 2.1

26.0 i 1.8*
31.9 i 1.8

27.3 f 1.8**
36.7 f 1.8

82.8 f 6.1**
113.7 f 6.8

+

aLinear effect, P < .01.
b ~ u a d r a t i ceffect, P < .05.
+, *, **Means within a trait, a t a specific time on feed, differ a t P < .lo,.O5,and .01,respectively.
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Anderson et a]., 1989; Koohmaraie et al., 19911, and
no BAA effect on ADG (Bohorov et al., 1987; Claeys et
al., 1989). The varied response in ADG may be due to
the type and dose of BAA, animal age, or the length of
treatment. Beermann et al. (1986), Claeys et al.
(1989), and Williams et al. (1989) have all reported
that young lambs ( < 20 kg) do not show a response in
ADG or feedlgain during BAA treatment. This may be
caused by a lower number of P-adrenergic receptors
(BAR) or by a reduction in the ability to stimulate
postreceptor events upon binding of the BAA to the
BAR (for review see Stiles et al., 1984).
The most consistent response noted in BAA-treated
animals is an increase in the weight of various
muscles (Yang and McElligott, 19891, with the most
prominent increase in muscles dominated by Type I1
fibers (Beermann et al., 1987). Based on the results of
this study and other studies using lambs (Wang and
Beermann, 1988) and rats (Reeds et al., 19861, it
seems that BAA administration has its greatest effect
on muscle growth during the first 2 to 3 wk of
treatment. This muscle accretion could occur from
increased protein synthesis, as reported for pigs fed
ractopamine (Helferich et al., 1990) and rats fed
clenbuterol and fenoterol (Emery et al., 1984) or from
decreased protein degradation, as reported for lambs
(Bohorov et al., 1987) and rats (Reeds et al., 1986)
fed clenbuterol. Alternatively, Anderson et al. (1991)
suggested a biphasic response of muscle to BAA
treatment, whereby protein degradation was initially
reduced followed by increased protein synthesis with
chronic treatment.
Administration of BAA has been reported to decrease the proteolytic capability of the muscle through
alteration of the calpain-calpastatin complex (Higgins
et al., 1988; Wang and Beermann, 1988; Forsberg et
al., 1989; Kretchmar et al., 1989; Koohmaraie et al.,
1991). We found that the greatest changes in activity
of this system occurred during the first 2 wk of
treatment and involved a decrease in p-calpain
activity, an increase in calpastatin activity, and no
change in m-calpain activity. The similarity between
the response of calpastatin activity (Figure 3 ) and
muscle weight (Figure 1) suggests that an increase in
calpastatin activity may be related to BAA-induced
muscle growth.
The results from BAA treatment on the cathepsins
vary, with reports of increased activity (McElligott et
al., 1987; Koohmaraie et al., 1991), decreased activity
(Kretchmar et al., 1989; Morgan et al., 1989; B6chet
et al., 1990), or no change in activity (Forsberg et al.,
1989). In our study, activity of the catheptic system
increased, suggesting an increase in the proteolytic
capability of the longissimus muscle (Table 2 ) .
Although the role of the catheptic proteinases in
skeletal muscle turnover is unknown, the increased
cathepsin activity in BAA-treated animals in the
present study did not prevent an increased rate of net
muscle protein accumulation. Go11 et al. (1989)
suggested a role for this system in the control of
sarcoplasmic protein turnover.

Most researchers have proposed a hypertrophic
model for BAA-induced muscle growth (Beermann et
al., 1987; Kim et al., 1987; Koohmaraie et a]., 1991),
a s opposed to models for compensatory muscle growth
(Beermann, 1983) or somatotropin-induced muscle
growth (for review see Boyd and Bauman, 1989). Our
longissimus data are consistent with these findings.
The semitendinosus data (Table 4 ) also agree with
the hypertrophic model of growth up to 4 wk of
treatment. However, after 6 wk of treatment, the
semitendinosus muscle seemed to grow through some
mechanism other than strict hypertrophy. Although
the incorporation of satellite cells or hyperplastic
muscle growth is not consistent with most of the BAA
data, it has been suggested as a possibility in rabbits
fed cimaterol (Forsberg et al., 1989) and may
partially explain the long-term differences noted in
semitendinosus weight.
In agreement with previous studies (Beermann et
al., 1987; Williams et al., 1989; Koohmaraie et al.,
1991), the present study finds that transcriptional
activity (RNA:DNA ratio) is higher in muscle from
BAA-fed animals than in muscle from control animals.
There was attenuation in the transcriptional activity
of muscle from BAA-treated lambs after 4 and 6 wk.
Attenuation to BAA treatment has been reported
previously (Eisemann et al., 1988; Yang and McE1ligott, 1989) and may be due to down-regulation of the
BAR. Kim et al. (1992) reported this phenomenon in
rat skeletal muscle, noting a 26.8% decrease in the
number of 0-adrenergic binding sites with 3 d of BAA
treatment. Our data are consistent with the fact that
translational activity, protein:RNA ratio, of muscle is
generally not altered by BAA treatment. Collectively,
the nucleic acid and protein data in our study and
previous studies suggest that BAA treatment increases the protein synthetic capacity of muscle. As
suggested by Anderson et al. (19911, our data imply
that the decreased muscle protein degradation, due to
changes in the calpain/calpastatin complex, coupled
with the increased muscle protein synthetic capacity
may account for the lean growth of BAA-treated
animals.
Our tenderness data agree with previous findings
(Morgan et al., 1989; Koohmaraie and Shackelford,
1991; Koohmaraie et al., 1991) that the meat from
BAA-treated animals is consistently tougher than
untreated meat and responds less favorably to aging.
Responses of shear force (Figure 4) and calpastatin
activity (Figure 3 ) were similar, and elevated calpastatin activity has been implicated in BAA-induced
toughening of meat (Koohmaraie et al., 1991). These
data imply that the increase in calpastatin activity
may be related to both the decreased tenderness and
decreased response to aging in meat from BAA-treated
animals.
Because this study monitored the effects of BAA
administration over a 6-wk period, it was possible to
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show the rapid response and subsequent attenuation
elicited by these compounds. Measurable changes
occur in muscle weight and metabolism within 2 wk of
treatment. Also, there seems to be a differential
response of the longissimus and semitendinosus muscles to BAA treatment. Kim et al. (1987) and
Beermann et al. (1987) reported that muscle fiber
type influenced the response of muscle to BAA
treatment. They noted a larger growth in the Type I1
(glycolytic) fibers than in the Type I (oxidative)
fibers, which may explain some of the differential
responses in the two muscles measured in this study.

Implications
This study shows that the /3-adrenergic agonists
may act on the calpain-calpastatin system to stimulate muscle growth through a decrease in protein
degradation. Decreased protein degradation has been
suggested as the most efficient means of increasing
muscle protein accretion. Therefore, a better understanding of the mechanisms that control these proteinases and protein degradation may allow improvement of animal growth efficiency.
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